Table 3.
Logistic regression analysis to show MACE predicted by CHA2DS2‐VASc score in all patients.
| Scoring algorithm | Univariable analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p | AOR | 95% CI | p | |
| CHA2DS2‐VASc (continuous variable)a | 1.41 | 1.25–1.58 | <.001 | 1.43 | 1.27–1.62 | <.001 |
| CHA2DS2‐VASc (category variable)b | ||||||
| 1 | Reference | – | – | Reference | – | – |
| 2–3 | 4.36 | 1.85–10.31 | .001 | 4.62 | 1.94–11.00 | .001 |
| 4–5 | 7.28 | 3.02–17.60 | <.001 | 7.74 | 3.18–18.89 | <.001 |
| > 5 | 10.49 | 3.78–29.10 | <.001 | 11.71 | 4.14–33.15 | <.001 |
Abbreviation: AOR, adjusted odds ratio; CI, confidence interval; MACE, major adverse cardiovascular event; OR, odds ratio.
a
The multivariable analysis model included the CHA2DS2‐VASc score as a continuous variable, creatinine, total cholesterol and left ventricular ejection fraction.
b
The multivariable analysis model included the CHA2DS2‐VASc score as a category variable, creatinine, total cholesterol and left ventricular ejection fraction.